Navigation Links
Shire in Medical News

AspireHR Completes Phase 1 SAP HR Initiative for Shire Pharmaceuticals

AspireHR and Shire Pharmaceuticals complete Phase 1 of their shared SAP human resources initiative. Wayne, PA (PRWEB) August 7, 2009 -- AspireHR, an SAP HR software, consulting, and SaaS company, is proud to announce the successful Go-Live of Phase 1 of their SAP HR ini...

GlaxoSmithKline and Shire Enter Agreement to Co-Promote Vyvanse(R) (lisdexamfetamine dimesylate) CII for Adult Attention Deficit Hyperactivity Disorder

RESEARCH TRIANGLE PARK, N.C., March 31 /PRNewswire-FirstCall/ -- GlaxoSmithKline plc (NYSE: GSK ) has entered into a co-promotion agreement with Shire plc (LSE: SHP, Nasdaq: SHPGY ) for Vy v a n s e(R) , to help improve the recognition and treatment of adult Attention Deficit Hyperactivi...

VIDEO from Medialink and Shire plc: Rare Diseases Must Be Top of the Health Agenda

First European Rare Disease Day highlights impact on people affected by rare diseases NEW YORK, Feb. 28 /PRNewswire/ -- European Rare Disease Day -- The first ever European Rare Disease Day will be launched on Friday 29 February...because it's a rare day that only c...

The Lachlan Shire Council To Fund GP For Condobolin Health Service

The Lachlan Shire Council decides to pay for the services of another doctor at the Condobolin Aboriginal Health Service. // The council have decided to give the Condobolin Aboriginal Health Service $150,000 so as to pay a doctor to work as a general practitioner and be a second visiting medic...

More Study On Side Effects of ADHD Drug Needed: Shire Pharmaceuticals

Drugs meant for treatment of Attention Deficit Hyperactivity Disorder (ADHD), Ritalin (Novartis AG) and Adderall (Shire Pharmaceuticals) would be subjected to stringent clinical trials to assess the safety and side effects // of the drug. The decision has been taken following the reports of t...

VYVANSE CII provided significant efficacy at 14 hours in adults with ADHD

... Hollywood, FL July 1, 2009 shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical compa...over 12 percent based on weekly branded prescription volume. Additionally, shire has executed agreements with 10 of Shire's top 11 managed care organization...

Global Autoimmune Disease Therapeutics Market to Reach $50 Billion by 2015, According to a New Report by Global Industry Analysts

...e AG, Genentech, Inc., GlaxoSmithKline plc, Johnson & Johnson, Inc., Merck Serono SA, Novartis AG, sanofi-aventis SA, Schering-Plough Corporation, shire Pharmaceuticals Group plc., Teva Pharmaceuticals Industries Limited, UCB Pharma. "Autoimmune Disease Therapeutics: A Global Strategic Busine...

Shire's INTUNIV (Guanfacine) extended release in children with ADHD and oppositional symptoms

... San Francisco, CA May 18, 2009 shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical compa...UNIV for treating ADHD in this patient population." On January 26, 2009, shire filed a resubmission to the US Food and Drug Administration (FDA) of the Ne...

Shire Expands Gastrointestinal Patient Assistance Program for Uninsured or Unemployed Americans

... Free Medication Provided by shire to Patients Taking Lialda(R) (mesalamine) or Penta... PHILADELPHIA, May 18 /PRNewswire-FirstCall/ -- shire plc (LSE: SHP, Nasdaq: SHPGY ), the global speci... prescribed gastrointestinal (GI) medications from shire by expanding its Patient Assistant Program (PAP). ...

Shire to Present New Scientific Data on its ADHD Treatments at a National Scientific Meeting of Psychiatrists on May 18

... PHILADELPHIA, May 15 /PRNewswire-FirstCall/ -- shire plc (LSE: SHP, Nasdaq: SHPGY ), the global speci...or behavioral modification, and medication. shire PLC Shire's strategic goal is to become the ... on meeting the needs of the specialist physician. shire focuses its business on attention deficit hyperact...

For Dialysis Patients, More Pills = Lower Quality of Life

...fforts to reduce dialysis patients' pill burden must address the number of prescribed phosphate binders, the researchers said. The study, funded by shire Pharmaceuticals, appears in an upcoming issue of the Clinical Journal of the American Society of Nephrology . More information The National K...

Stepping Up: D.C. Wards 7 and 8 Teens to Teach Prevention of HIV, Obesity in Summer Youth Program

...mmit Health Institute for Research and Education ( shire ), Inc., is reaching out to 40 young men and women...l completion of the education part of the program, shire teen health educators take their knowledge and pee...e promotion of health and wellness for all people. shire works to eradicate health disparities and aid vuln...

Former Executive at Genzyme Corp. and Osiris Therapeutics, Inc. to Head Business Advisory Board at Rx for Africa, Inc.

...he company's first product, Replagal, an orphan drug for Fabry's disease. The drug took 75% market share in Europe. In 2005, Transkaryotic was sold to shire Pharmaceuticals for $1.6 billion. He has also achieved great success with reimbursement programs for the drugs he has marketed. "With Ceradase, we wer...

MicroMass Promotes Kim Levy To Senior Vice President

...rapeutic categories, MicroMass has a roster of clients that includes GlaxoSmithKline, Johnson & Johnson, LabCorp, Merck & Co., Inc., Novartis, shire and UCB Pharma. For additional information on MicroMass, visit www.micromass.com . CONTACT: Julie Laitin (212) 286-2424 Cy...

Non-safety-related voluntary market withdrawal of a limited portion of DAYTRANA(R) (methylphenidate transdermal system) patches announced

... PHILADELPHIA, March 20 /PRNewswire-FirstCall/ -- shire plc (LSE: SHP, Nasdaq: SHPGY ), the global speci...atches affected by this action are listed below). shire is taking this action because some DAYTRANA patche...Pharmaceuticals, Inc. continues to manufacture and shire continues to promote DAYTRANA in the United States...

National Audience of Psychiatrists Assembling in Chicago for Conference on Bipolar Disorder and ADHD

...er and ADHD. *Exhibiting companies include: AstraZeneca, Neuronetics, Prescribing for Better Outcomes ( University of North Carolina ), shire Pharmaceuticals and Teva Pharmaceuticals. Dowden Health Media, a division of Lebhar-Friedman, Inc., publishes CURRENT PSYCHIATRY and other peer-...

Shire Celebrates World Rare Disease Day on February 28

...ity CAMBRIDGE, Mass., Feb. 26 /PRNewswire/ -- shire Human Genetic Therapies (HGT), a business unit of shire plc, the global specialty biopharmaceutical compan...ment and increased reimbursement for orphan drugs, shire HGT is developing a new, comprehensive online reso...

New Study Shares Benchmarks for Medical Science Liaisons: Gaining Access and Forging Relationships with Key Opinion Leaders

...study that included such influential companies as Astrazeneca, Boehringer Ingelheim, Eli Lilly, Genentech, Janssen, Medtronic, Novartis, Novo Nordisk, shire and many others, a variety of key topics were covered, including: Pre-Launch Service Activities Post-Launch Service Activiti...

VYVANSE provided behavior, inattention and math test score improvements in children with ADHD

... CHICAGO October 29, 2008 shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced results from a 13-hour analog classroom study in school...

WellSpring Pharmaceutical Corp. Names Wendy Shusko as New Chief Operating Officer

... the firm's CEO and Chairman. Dr. Vukovich previously founded and managed Roberts Pharmaceutical Corporation of Eatontown, NJ until its acquisition by shire Pharmaceutical Group in 1999. WellSpring owns and operates an FDA approved manufacturing plant in Oakville, Ontario, Canada. Its administrative headqu...

WellSpring Pharmaceutical Corp. Acquires Consumer Product Brands from McNeil Consumer Healthcare -- Deal Enhances US and Canadian Pharmaceutical Business

... the firm's CEO and Chairman. Dr. Vukovich previously founded and managed Roberts Pharmaceutical Corporation of Eatontown, NJ until its acquisition by shire Pharmaceutical Group in 1999. WellSpring owns and operates an FDA approved manufacturing plant in Oakville, Ontario, Canada. Its administrative headqu...

Mergent, Inc. Announces Changes to the HealthShares(TM) Ophthalmology Index

...euticals (Nasdaq: ISTA ) will replace Jerini AG (Frankfurt, Germany: JI4) in the HealthShares(TM) Ophthalmology Index. Jerini AG is being acquired by shire Limited (London Main Market, U.K.: SHP LO). (Logo: http://www.newscom.com/cgi-bin/prnh/20080204/CLM073LOGO ) Companies included in the HealthSha...

Long-term safety data on Lialda published in leading GI journal

... Basingstoke, UK and Philadelphia, US June 17, 2008 shire Limited (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced the publication of data from a randomized, long-ter...

Long-Term Safety Data on Lialda(TM) (mesalamine) for Patients With Ulcerative Colitis Published in Leading GI Journal

...mine with hydrophilic and lipophilic components. shire has licensed from Giuliani SpA the exclusive right... +44 1256 894 280 Notes to editors shire LIMITED Shire's strategic goal is to become the ... on meeting the needs of the specialist physician. shire focuses its business on attention deficit and hype...

Employee Engagement & Retention: Benchmarking Metrics and Networking Opportunity to Help Solve Today's Workforce Challenges

...Join Fortune 500 companies to share insights on talent retention and workforce management and learn from case studies presented by 3M, The Home Depot, shire Pharmaceuticals, Cardinal Health, Nationwide Insurance, Metlife and others at the 10th Annual Human Resources Conference: Leadership Development - Fin...

DRAXIS Health Reports Results for the First Quarter of 2008

... namely contingent milestone payments from shire BioChem Inc. of approximately $0.8 million...estone payments of approximately $0.8 million from shire BioChem Inc. (Shire) and an insurance payment of $... (198.6%) Adjustments: (a) Non-recurring shire milestone receipt(2) - ...

Phase III pivotal results presented of VYVANSE to treat ADHD in adults

... WASHINGTON, May 8 /PRNewswire-FirstCall/ -- shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical compa... included decreased appetite, insomnia and dry mouth. On April 23, 2008, shire received approval from the U.S. Food and Drug Administration (FDA) for VYVA...

Shire investigational nonstimulant INTUNIV showed significant efficacy in reducing ADHD symptoms

... WASHINGTON, May 7 -- shire plc(LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical compan...on (FDA) issued an approvable letter on June 20, 2007, regarding INTUNIV. shire is conducting additional clinical work which is designed to enhance the la...

New analysis shows DAYTRANA offered ADHD symptom control for 12 months

... Washington, D.C. May 7, 2008 shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced findings from a new data analysis that was conducted to...

Cadient Group Continues Winning Streak; Receives Multiple Honors at 2008 Pharmaceutical Advertising and Marketing Excellence Awards

...Best New Product Introduction Cadient Group was recognized with the silver award in the Best New Product Introduction category for its work on shire US, Inc.'s Vyvanse (lisdexamfetamine dimesylate) launch campaign -- Silver Award -- Best Interactive Consumer Campaign Cadient Group and Nov...

Shire to present ADHD treatments scientific data at American Psychiatric Assoc. Meeting

... PHILADELPHIA May 1, 2008 shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical compa...ation (APA) annual meeting to be held May 3rd to 8th in Washington, D.C. shire is committed to the advancement of ADHD research, and we are pleased to be ...

FDA approves VYVANSE, first and only once-daily prodrug stimulant to treat ADHD in adults

... Basingstoke, U.K. and Philadelphia, PA April 23, 2008 shire plc (LSE: SHP, NASDAQ: SHPGY,), the global specialty biopharmaceutical company, today announced that it has received approval from the U.S. Food and D...

Retooling Talent Management Approaches to Find, Grow & Retain Tomorrow's Leaders

...iness partner, moving talent management initiatives forward will require organizational buy-in and commitment. Thought leaders from Cardinal Health, shire Pharmaceuticals, 3M Worldwide, SAS, MetLife Insurance, Home Depot, Qualcomm, Nationwide Insurance and others will address finding, growing and retaini...

AUDIO from Medialink and Shire: What It Means to be an Adult With ADHD

...tion is also prevalent in adults. Here's more with an expert on ADHD and the impact it can have on the lives of adults. Listen to this report from shire at: http://media.medialink.com/WebNR.aspx?story=34882 Registered journalists can access video, audio, text, graphics and photos for free and unrest...

QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes

...tsubishi Tanabe Pharma Corporation (TSE: 4508) Cancer Index (HHK) Drop shire PLC (Nasdaq: SHPGY ) Add Ark Therapeutics Group Plc (LSE: AKT.L) Card...utical Co., Ltd. (TSE: 4535.T) Dermatology and Wound Index (HRW) Drop shire PLC (ADR) (Nasdaq: SHPGY ) SkyePharma Plc (LSE: SKP.LN) Add Standard ...

Shire Launches Patient Education Forums on Better Managing the Challenges of Ulcerative Colitis

...ties PHILADELPHIA, March 9 /PRNewswire/ -- Today shire Pharmaceuticals launched "On the Road Again," an i...he Internet and building an online UC community. shire developed the program, scheduled to travel to 10 m... please visit http://www.RoadtoUCLearning.com . shire Pharmaceuticals is a specialty biopharmaceutical c...

Healthcare Businesswomen's Association Names Genentech's Leonard Kanavy, Vice President, Commercial Operations as the 2008 Honorable Mentor

...artis Oncology -- 2005 -- Mick Mosebrook, then Executive Vice President, Sales, U.S. Pharmaceuticals, Pfizer, Inc. -- 2006 -- Matthew Emmens, CEO, shire Pharmaceuticals -- 2007 -- Lonnel Coats, President and COO, Eisai Inc. Star Volunteer Each year, the HBA also honors a star volunteer who stan...

DRAXIS Health Reports Fourth Quarter and Year End Results

... (a) Non-recurring (791) - shire milestone receipt(2) - - ... (a) Non-recurring shire milestone - - receipt(2) (0.01) - ...

FDA approves additional dosage strengths of Vyvanse

... PHILADELPHIA January 3, 2008 shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ), the globa...ent, VYVANSE™ (lisdexamfetamine dimesylate). shire expects the three additional dosage strengths of 2...vailable in pharmacies throughout the country. shire is pleased that physicians will soon have the bene...

Nationwide survey reveals differing physician and patient perceptions regarding impact of UC

...ry Bowel Diseases conference. The series of surveys, titled UC: NORMAL (New Observations on Remission Management and Lifestyle), were sponsored by shire Pharmaceuticals, a specialty biopharmaceutical company, which markets once-daily LIALDA and PENTASA (mesalamines) for UC. Before these surveys, pa...
Other Tags
(Date:9/19/2014)... the sake of fairness per se but in order ... Frans de Waal, PhD, and Sarah Brosnan, PhD, co-authors ... is defined as a negative reaction to unequal outcomes. ... , Their conclusion comes after the co-authors reviewed more ... it is the evolution of forestalling partner dissatisfaction with ...
(Date:9/19/2014)... study shows that legume plants regulate their symbiotic ... that are transmitted through the plant structure from ... of bacteria-holding nodules in the roots. This collaborative ... Institute for Basic Biology, the Graduate University for ... Sustainable Resource Science in Japan. , Legumes, ...
(Date:9/18/2014)... A sleep-promoting circuit located deep in the primitive ... Discovered by researchers at Harvard School of Medicine and ... Sciences, this is only the second "sleep node" identified ... both necessary and sufficient to produce deep sleep. , ... the study demonstrates that fully half of all of ...
Breaking Biology News(10 mins):Evolution of responses to (un)fairness 2Evolution of responses to (un)fairness 3For legume plants, a new route from shoot to root 2No sedative necessary: Scientists discover new 'sleep node' in the brain 2
(Date:9/20/2014)... September 21, 2014 Diabetes Protocol ... Pullman that is helping thousands of people learn how ... without shots, pills, or prescriptions has caught the attention ... “There are currently tens of millions of people in ... and Type 2 diabetes, and unfortunately, big pharma makes ...
(Date:9/20/2014)... GA (PRWEB) September 20, 2014 David ... 20, 2014. The first poster looked at the clinical ... cardiac cycle for calculating diastolic function. In conjunction with ... end-stage renal disease and normal LVEF by echo (>50%). ... stress protocol, and standard SPECT. Emory Toolbox 4.0 ...
(Date:9/20/2014)... September 21, 2014 Increases in ... to greater waste treatment volumes. However, government regulations ... waste from landfill. According to IBISWorld industry analyst ... implemented strategies aimed at reducing the volume of ... recycled and recovered.” Still, a large proportion of ...
(Date:9/20/2014)... September 20, 2014 On Monday, September ... $250,000 pediatric cancer research grant from Hyundai Hope on ... University Children’s Hospital located on 11234 Anderson St., in ... Dr. Kimberley Payne, Associate Professor at Loma Linda University ... on leukemia in children. , Loma Linda ...
(Date:9/20/2014)... (PRWEB) September 20, 2014 Lifeinsurancequoteterm.net ... advantages a no medical exam life insurance plan provides ... for vulnerable family members should be a top priority ... for life insurance without taking medical examinations and visiting ... not require medical examinations will provide coverage up to ...
Breaking Medicine News(10 mins):Health News:Diabetes Protocol: Review Exposes Kenneth Pullman’s Breakthrough Discovery About Diabetes Management 2Health News:Versatility of Emory Toolbox 4.0 Shown at ASNC in Scientific Posters 2Health News:Versatility of Emory Toolbox 4.0 Shown at ASNC in Scientific Posters 3Health News:Waste Treatment and Disposal Services in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Waste Treatment and Disposal Services in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Loma Linda University Medical Center Receives $250,000 Research Grant From Hyundai Hope On Wheels In Honor Of National Childhood Cancer Awareness Month 2Health News:Loma Linda University Medical Center Receives $250,000 Research Grant From Hyundai Hope On Wheels In Honor Of National Childhood Cancer Awareness Month 3Health News:No Medical Exam Life Insurance Provides Financial Protection for Families 2
Other Contents